T. Rowe Price Investment Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.12M | Sell |
474,758
-1,523,233
| -76% | -$26M | 0.01% | 568 |
|
|
2025
Q1 | $128M | Buy |
1,997,991
+41,408
| +2% | +$2.64M | 0.08% | 233 |
|
|
2024
Q4 | $238M | Buy |
1,956,583
+10,343
| +0.5% | +$1.26M | 0.15% | 155 |
|
|
2024
Q3 | $243M | Sell |
1,946,240
-12,395
| -0.6% | -$1.55M | 0.15% | 163 |
|
|
2024
Q2 | $309M | Buy |
1,958,635
+27,088
| +1% | +$4.28M | 0.2% | 124 |
|
|
2024
Q1 | $250M | Buy |
1,931,547
+11,805
| +0.6% | +$1.53M | 0.15% | 161 |
|
|
2023
Q4 | $185M | Buy |
1,919,742
+24,422
| +1% | +$2.36M | 0.12% | 196 |
|
|
2023
Q3 | $230M | Buy |
+1,895,320
| New | +$230M | 0.16% | 157 |
|